Brief: Bergenbio Names Cristina Oliva As Chief Medical Officer
11/04/2022 06:07
April 11 (Reuters) - Bergenbio ASA BGBIO.OL :
* NAMES CRISTINA OLIVA AS CHIEF MEDICAL OFFICER (CMO), EFFECTIVE 25 APRIL 2022
Source text for Eikon: ID:nObiS9cdBa
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee